AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FIREBRICK PHARMA LTD

0.033

+0.0013.13%

Volume:44.60K

Turnover:1K

Market Cap:9.48M

PE:-3.11

High:0.033

Open:0.029

Low:0.029

Close:0.032

52wk High:0.078

52wk Low:0.024

Shares:287.20M

Float Shares:106.88M

Volume Ratio:0.80

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.011

EPS(LYR):-0.013

ROE:-142.70%

ROA:-72.20%

PB:4.89

PE(LYR):-2.63

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Blue Owl Capital (OWL) Stock Faces Margin Strain Despite Fee Growth

Simply Wall St.

Firebrick Pharma Ltd-change of Address

THOMSON REUTERS

Firebrick Pharma Ltd-Nasodine Composition Patent Granted in New Zealand

THOMSON REUTERS

Firebrick Pharma Ltd-Close of Offer - Listing Options

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/FRE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.033,"timestamp":1787897520000,"preClose":0.032,"halted":0,"volume":44599,"delay":0,"changeRate":0.03125000000000003,"nameEN":"FIREBRICK PHARMA LTD","floatShares":106875635,"shares":287198985,"eps":-0.010606,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"08-28 16:12:00 AEST","open":0.029,"high":0.033,"low":0.029,"amount":1451,"amplitude":0.125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.010606,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788134400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.032,"openAndCloseTimeList":[[1787875200000,1787896800000]],"volumeRatio":0.8015780286467004,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"FRE.AU","preClose":0.029,"auctionPrice":0.029,"auctionVolume":25000,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724326286}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":106875635,"roa":"-72.20%","roe":"-142.70%","lyrEps":-0.012528,"volumeRatio":0.8015780286467004,"shares":287198985,"dividePrice":0,"high":0.033,"amplitude":0.125,"preClose":0.032,"low":0.029,"week52Low":0.024,"pbRate":"4.89","psRate":"23.08","week52High":0.078,"institutionHeld":0,"latestPrice":0.033,"eps":-0.010606,"divideRate":0,"volume":44599,"delay":0,"ttmEps":-0.010606,"open":0.029,"prevYearClose":0.053,"prevWeekClose":0.033,"prevMonthClose":0.026,"prevQuarterClose":0.036,"fiveDayClose":0.027,"twentyDayClose":0.026,"sixtyDayClose":0.042},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656392944","title":"Blue Owl Capital (OWL) Stock Faces Margin Strain Despite Fee Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656392944","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656392944?lang=en_us&edition=fundamental","pubTime":"2026-08-01 07:23","pubTimestamp":1785540193,"startTime":"0","endTime":"0","summary":"Blue Owl Capital stock inched up about 1.4% to US$10.30 after earnings, a relatively calm move for a company that just put a very rich 86x P/E and an almost 9% dividend yield back under the microscope. The headline this quarter is margin pressure. Quarterly basic EPS landed at a little under US$0.02 and trailing net profit margin sits at 2.7%, with results still carrying the weight of a US$262.4m one off loss.\nShort term traders may focus on the modest price gain. Long term holders will be...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-owl/blue-owl-capital/news/blue-owl-capital-owl-stock-faces-margin-strain-despite-fee-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-owl/blue-owl-capital/news/blue-owl-capital-owl-stock-faces-margin-strain-despite-fee-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4135","IE00BBT3K403.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE00BN8TJ469.HKD","FRE.AU","OWL","LRCY","BK7096","PSP","PEVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651230241","title":"Firebrick Pharma Ltd-change of Address","url":"https://stock-news.laohu8.com/highlight/detail?id=2651230241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651230241?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:00","pubTimestamp":1783994410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUE1QJP9W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640489929","title":"Firebrick Pharma Ltd-Nasodine Composition Patent Granted in New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2640489929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640489929?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:20","pubTimestamp":1780438854,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7SLL2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636816352","title":"Firebrick Pharma Ltd-Close of Offer - Listing Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2636816352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636816352?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:50","pubTimestamp":1779259828,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUE5XSD6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FRE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}